Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.
Introduction
Company name: Pfizer Limited
Address: Ramsgate Road
Sandwich
Kent CT13 9NJ
Telephone: 0845 300 8034 (Out of hours: 01304 616161)
Fax: 01737 332521
Email: UKVetLine@pfizer.com
Website: www.pfizerah.co.uk
Presentation
A pale yellow, pork-flavoured tablet containing 50 mg praziquantel, 50 mg pyrantel (equivalent to 144 mg pyrantel embonate) and 150 mg febantel.
Uses
Cazitel Plus Tablets are indicated for the treatment of mixed infections by nematodes and cestodes of the following species in dogs:
Nematodes:
Ascarids: Toxocara canis, Toxascaris leonina (adult and late immature forms).
Hookworms: Uncinaria stenocephala, Ancylostoma caninum (adults).
Whipworms: Trichuris vulpis (adults).
Cestodes:
Tapeworms: Echinococcus species, (E. granulosus, E. multilocularis), Taenia species, (T. hydatigena, T. pisiformis, T. taeniformis), Dipylidium caninum (adult and immature forms).
Dosage and administration
For oral administration only.
The recommended dose rates are 15 mg/kg bodyweight febantel, 5 mg/kg pyrantel (equivalent to 14.4 mg/kg pyrantel embonate) and 5 mg/kg praziquantel. This is equivalent to 1 tablet per 10 kg bodyweight.
The tablets can be given directly to the dog or disguised in food. No starvation is needed before or after treatment.
To ensure administration of a correct dose, bodyweight should be determined as accurately as possible.
Dosage table (guide):
Bodyweight (kg)
| Tablets
|
½ - 2
| ¼
|
3 - 5
| ½
|
6 - 10
| 1
|
11 - 15
| 1 ½
|
16 - 20
| 2
|
21 - 25
| 2 ½
|
26 - 30
| 3
|
31 - 35
| 3 ½
|
36 - 40
| 4
|
> 40
| 1 tablet per 10 kg
|
If there is a risk of re-infestation, the advice of a veterinarian should be sought regarding the need for and the frequency of repeat administration.
Contra-indications, warnings, etc
Do not use simultaneously with piperazine compounds as the anthelmintic effects of pyrantel and piperazine may be antagonized.
Do not use in animals with a known sensitivity to the active ingredients or to any of the excipients.
Fleas serve as intermediate hosts for one common type of tapeworm Dipylidium caninum. Tapeworm infestation is certain to reoccur unless control of intermediate hosts such as fleas, mice, etc. is undertaken.
Tapeworm infestation is unlikely in pups less than 6 weeks of age.
Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.
Concurrent use with other cholinergic compounds can lead to toxicity.
Teratogenic effects attributed to high doses of febantel have been reported in sheep and rats. No studies have been performed in dogs during early pregnancy.
Use of the product during pregnancy should be in accordance with a benefit risk assessment by the responsible veterinarian. It is recommended that the product is not used in dogs during the first 4 weeks of pregnancy. Do not exceed the stated dose when treating pregnant bitches.
User warnings
In case of accidental ingestion, seek medical advice and show the package leaflet to the physician.
In the interests of good hygiene, persons administering the tablets directly to the dog, or by adding them to the dog’s food, should wash their hands afterwards.
Pharmaceutical precautions
No special storage conditions required.
Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.
Discard any unused divided tablets.
Keep out of the reach and sight of children.
For animal treatment only.
Legal category
NFA-VPS
Packaging Quantities
Cartons containing 104 tablets.
Further information
The combination of praziquantel, pyrantel embonate and febantel is well tolerated in dogs. In safety studies, a single dose of 5 times the recommended dose or greater gave rise to occasional vomiting.
Marketing authorisation number
Vm 08749/4026.
Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.
Introduction
Company name: Pfizer Limited
Address: Ramsgate Road
Sandwich
Kent CT13 9NJ
Telephone: 0845 300 8034 (Out of hours: 01304 616161)
Fax: 01737 332521
Email: UKVetLine@pfizer.com
Website: www.pfizerah.co.uk
Presentation
A pale yellow, pork-flavoured tablet containing 50 mg praziquantel, 50 mg pyrantel (equivalent to 144 mg pyrantel embonate) and 150 mg febantel.
Uses
Cazitel Plus Tablets are indicated for the treatment of mixed infections by nematodes and cestodes of the following species in dogs:
Nematodes:
Ascarids: Toxocara canis, Toxascaris leonina (adult and late immature forms).
Hookworms: Uncinaria stenocephala, Ancylostoma caninum (adults).
Whipworms: Trichuris vulpis (adults).
Cestodes:
Tapeworms: Echinococcus species, (E. granulosus, E. multilocularis), Taenia species, (T. hydatigena, T. pisiformis, T. taeniformis), Dipylidium caninum (adult and immature forms).
Dosage and administration
For oral administration only.
The recommended dose rates are 15 mg/kg bodyweight febantel, 5 mg/kg pyrantel (equivalent to 14.4 mg/kg pyrantel embonate) and 5 mg/kg praziquantel. This is equivalent to 1 tablet per 10 kg bodyweight.
The tablets can be given directly to the dog or disguised in food. No starvation is needed before or after treatment.
To ensure administration of a correct dose, bodyweight should be determined as accurately as possible.
Dosage table (guide):
| Bodyweight (kg) | Tablets |
|
½ - 2 |
¼ |
|
3 - 5 |
½ |
|
6 - 10 |
1 |
|
11 - 15 |
1 ½ |
|
16 - 20 |
2 |
|
21 - 25 |
2 ½ |
|
26 - 30 |
3 |
|
31 - 35 |
3 ½ |
|
36 - 40 |
4 |
|
> 40 |
1 tablet per 10 kg |
If there is a risk of re-infestation, the advice of a veterinarian should be sought regarding the need for and the frequency of repeat administration.
Contra-indications, warnings, etc
Do not use simultaneously with piperazine compounds as the anthelmintic effects of pyrantel and piperazine may be antagonized.
Do not use in animals with a known sensitivity to the active ingredients or to any of the excipients.
Fleas serve as intermediate hosts for one common type of tapeworm Dipylidium caninum. Tapeworm infestation is certain to reoccur unless control of intermediate hosts such as fleas, mice, etc. is undertaken.
Tapeworm infestation is unlikely in pups less than 6 weeks of age.
Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.
Concurrent use with other cholinergic compounds can lead to toxicity.
Teratogenic effects attributed to high doses of febantel have been reported in sheep and rats. No studies have been performed in dogs during early pregnancy.
Use of the product during pregnancy should be in accordance with a benefit risk assessment by the responsible veterinarian. It is recommended that the product is not used in dogs during the first 4 weeks of pregnancy. Do not exceed the stated dose when treating pregnant bitches.
User warnings
In case of accidental ingestion, seek medical advice and show the package leaflet to the physician.
In the interests of good hygiene, persons administering the tablets directly to the dog, or by adding them to the dog’s food, should wash their hands afterwards.
Pharmaceutical precautions
No special storage conditions required.
Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.
Discard any unused divided tablets.
Keep out of the reach and sight of children.
For animal treatment only.
Legal category
NFA-VPS
Packaging Quantities
Cartons containing 104 tablets.
Further information
The combination of praziquantel, pyrantel embonate and febantel is well tolerated in dogs. In safety studies, a single dose of 5 times the recommended dose or greater gave rise to occasional vomiting.
Marketing authorisation number
Vm 08749/4026.
